PMC:7600245 / 30499-30763
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T114 | 62-70 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T279 | 19-20 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T280 | 38-43 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T281 | 184-185 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T282 | 260-262 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T439 | 38-43 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T440 | 143-162 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T441 | 143-152 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T442 | 153-162 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T225 | 0-264 | Sentence | denotes | In this direction, a randomized, open-label trial in China in COVID-19 patients (n = 199), who were hospitalized with severe illness, compared lopinavir/ritonavir (400 mg/100 mg twice a day for 14 days) along with the standard care to the standard care alone [94]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 895 | 71-79 | Species | denotes | patients | Tax:9606 |
| 901 | 143-162 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 916 | 62-70 | Disease | denotes | COVID-19 | MESH:C000657245 |